24 Results for "

pan caspase

" in MedChemExpress (MCE) Product Catalog:
Products (24)

24 Results for "pan caspase" in MCE Product Catalog:

819
819 Publications Verification
Referencia número: HY-16658B
No. CAS: 161401-82-7
Synonyms: Z-VAD(OH)-FMK
Z-VAD-FMK is a pan-caspase inhibitor and also an ICE-like protease inhibitor, which inhibits apoptosis by preventing the processing of CPP32 to its active form. Z-VAD-FMK sensitivity varies primarily due to differential expression of receptor-interacting protein 1 (RIP1). Z-VAD-FMK limits the cryopreservation-induced apoptosis by reducing caspase-3 activity of in vitro produced bovine embryos. Z-VAD-FMK is immunosuppressive in vitro and inhibits T cell proliferation without blocking the processing of caspase-8 and caspase-3. Z-VAD-FMK leads to a decrease in intracellular glutathione (GSH) with a concomitant increase in reactive oxygen species (ROS) levels in activated T cells. Z-VAD-FMK is due to oxidative stress via the depletion of GSH. Z-VAD-FMK can be used for the study of acute pancreatitis .
loading...
    loading...
207
207 Cited Publications
Referencia número: HY-16658
No. CAS: 187389-52-2
Synonyms: Z-Val-Ala-Asp(OMe)-FMK
Target:  

Caspase

Áreas de investigación:  

Cancer

Z-VAD(OMe)-FMK (Z-Val-Ala-Asp(OMe)-FMK) is a cell-permeable and irreversible pan-caspase inhibitor . Z-VAD(OMe)-FMK is an ubiquitin carboxy-terminal hydrolase L1 (UCHL1) inhibitor. Z-VAD(OMe)-FMK irreversibly modifies UCHL1 by targeting the active site of UCHL1 .
loading...
    loading...
113
113 Cited Publications
Referencia número: HY-12305
No. CAS: 1135695-98-5
Pureza:  99.92%
Synonyms: QVD-OPH; Quinoline-Val-Asp-Difluorophenoxymethylketone
Target:  

Caspase HIV

Áreas de investigación:  

Infection Cancer

Q-VD-OPh is an irreversible pan-caspase inhibitor with potent antiapoptotic properties; inhibits caspase 7 with an IC50 of 48 nM and 25-400 nM for other caspases including caspase 1, 3, 8, 9, 10, and 12. Q-VD-OPh can inhibits HIV infection. Q-VD-OPh is able to cross the blood-brain barrier.
loading...
    loading...
57
57 Cited Publications
Referencia número: HY-10396
No. CAS: 254750-02-2
Pureza:  99.81%
Synonyms: PF 03491390; IDN-6556
Target:  

Caspase Flavivirus

Áreas de investigación:  

Infection Neurological Disease Cancer

Emricasan (PF 03491390) is an orally active and irreversible pan-caspase inhibitor. Emricasan inhibits Zika virus (ZIKV)-induced increases in caspase-3 activity and protected human cortical neural progenitors .
loading...
    loading...
23
23 Cited Publications
Referencia número: HY-164388
No. CAS: 162852-62-2
Áreas de investigación:  

Cardiovascular Disease Cancer

Z-VAD is an irreversible, broad-spectrum pan-caspase inhibitor that can inhibit a variety of caspases including caspase-3, -6, -7, -8, -9, etc. (with a weaker inhibitory effect on caspase-2). Z-VAD can block apoptosis signaling pathways, induce autophagy and necrosis in tumor cells, and has anti-angiogenic activity. Z-VAD can enhance the sensitivity of breast cancer and lung cancer cells to radiotherapy in vitro and in vivo, and prolong the growth delay of tumor xenograft models. Z-VAD is well tolerated and is mainly used in research related to cancer radiosensitization and cell death pathway regulation .
loading...
    loading...
18
18 Cited Publications
Referencia número: HY-10985
No. CAS: 437742-34-2
Pureza:  99.13%
Synonyms: Salinosporamide A; NPI-0052
Marizomib (Salinosporamide A) is a second-generation, irreversible, brain-penetrant, pan-proteasome inhibitor. Marizomib inhibits the CT-L (β5), CT-T-laspase-like (C-L, β1) and trypsin-like (T-L, β2) activities of the 20S proteasome (IC50=3.5, 28, and 430 nM, respectively) .
loading...
    loading...
4
4 Cited Publications
Referencia número: HY-13265
No. CAS: 935881-37-1
Pureza:  98.52%
Synonyms: HDAC-42; OSU-HDAC42
Target:  

HDAC Autophagy Apoptosis

Áreas de investigación:  

Cancer

AR-42 (HDAC-42; OSU-HDAC42) is a potent, orally bioavailable pan-HDAC inhibitor (IC50=16 nM). AR-42 induces growth inhibition, cell-cycle arrest, apoptosis, and activation of caspases-3/7. AR-42 promotes hyperacetylation of H3, H4, and alpha-tubulin, and up-regulation of p21. AR-42 shows cytotoxicity against various human cancer cell lines .
loading...
    loading...
Referencia número: HY-107194
No. CAS: 102586-30-1
Pureza:  99.07%
Áreas de investigación:  

Cancer

NSC12 is an orally active pan-FGF trap. NSC12 inhibits the interaction between FGF2/FGFR. NSC12 suppresses the phosphorylation of FGFR3. NSC12 reduces c-Myc levels, induces DNA damage, triggers the cleavage of Caspase 3, and promotes ROS production. NSC12 exhibits anticancer activity against lung cancer and multiple myeloma .
loading...
    loading...
Referencia número: HY-12305A
Synonyms: (R)-QVD-OPH; (R)-Quinoline-Val-Asp-Difluorophenoxymethylketone
Target:  

Apoptosis

Áreas de investigación:  

Cancer

(R)-Q-VD-OPh ((R)-QVD-OPH) is the less active enantiomer of Q-VD-OPha. Q-VD-OPha is an irreversible pan-caspase inhibitor with potent antiapoptotic properties.
loading...
    loading...
Referencia número: HY-114250
No. CAS: 2135511-22-5
Pureza:  99.84%
Synonyms: TRX-E-002-1
Target:  

Apoptosis

Áreas de investigación:  

Cancer

Cantrixil (TRX-E-002-1), an active enantiomer of TRX-E-002, is a second-generation super-benzopyran (SBP) compound. Cantrixil increases phosphorylated c-Jun levels resulting in caspase-mediated apoptosis in ovarian cancer cells. Cantrixil has potent pan anti-cancer activity against a broad range of cancer phenotypes .
loading...
    loading...
Referencia número: HY-151966
No. CAS: 3037417-26-5
Pureza:  99.49%
Áreas de investigación:  

Cancer

TD1092 is a pan-IAP degrader, degrades cIAP1, cIAP2, and XIAP. TD1092 activates Caspase 3/7, and promotes cancer cells apoptosis via IAP degradation. TD1092 inhibits TNFα mediated NF-κB pathway and reduces the phosphorylation of IKK, IkBα, p65, and p38. TD1092 can act as PROTAC, and is used for cancer research .
loading...
    loading...
Referencia número: HY-115590
No. CAS: 1902983-63-4
Áreas de investigación:  

Cancer

JP-11646 is a pan-PIM inhibitor with increased potency against PIM2 (IC50 = 0.5 nM). JP11646 is freely reversible and ATP non-competitive. JP-11646 results in a decrease of PIM1, 2, and 3 mRNA. JP-11646 can effectively inhibit cell viability in small cell lung cancer (SCLC) and large cell neuroendocrine carcinomas of the lung (LCNEC). JP-11646 can cause a decrease in p-4EBP-1 protein, increasing the cleavage of caspases while decreasing caspase-3. JP-11646 induces apoptosis or necroptosis in cells. JP-11646 leads to reductions in MYC paralogs. JP-11646 can be used for the study of SCLC, LCNEC, human acute leukemia (AML), multiple myeloma (MM), and triple-negative breast cancer (TNBC) .
loading...
    loading...
Referencia número: HY-16275
No. CAS: 908253-63-4
Synonyms: GS 9450; LB-84451
Áreas de investigación:  

Inflammation/Immunology

Nivocasan (GS 9450; LB-84451) is a pan-caspase inhibitor that irreversibly arrests caspase-1 activity and inhibits that of caspase-8. Nivocasan inhibits IL-1β cleavage and blocks osteoclast differentiation. Nivocasan inhibits the protein expression of NFATc1 and CSTK .
loading...
    loading...
Referencia número: HY-10396R
No. CAS: 254750-02-2
Synonyms: PF 03491390 (Standard); IDN-6556 (Standard)
Áreas de investigación:  

Infection Neurological Disease Cancer

Emricasan (Standard) is the analytical standard of Emricasan. This product is intended for research and analytical applications. Emricasan (PF 03491390) is an orally active and irreversible pan-caspase inhibitor. Emricasan inhibits Zika virus (ZIKV)-induced increases in caspase-3 activity and protected human cortical neural progenitors .
loading...
    loading...
Referencia número: HY-10396A
No. CAS: 409369-54-6
Synonyms: (2R,3S)-PF 03491390; (2R,3S)-IDN-6556
Target:  

Caspase Flavivirus

Áreas de investigación:  

Infection Neurological Disease Cancer

(2R,3S)-Emricasan ((2R,3S)-PF 03491390) is an isomer of Emricasan (HY-10396). Emricasan is an orally active and irreversible pan-caspase inhibitor. Emricasan inhibits Zika virus (ZIKV)-induced increases in caspase-3 activity and protected human cortical neural progenitors .
loading...
    loading...
Referencia número: HY-12305G
No. CAS: 1135695-98-5
Q-VD-OPh (GMP) is Q-VD-OPh (HY-12305) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. Q-VD-OPh is an irreversible pan-caspase inhibitor with potent antiapoptotic properties; inhibits caspase 7 with an IC50 of 48 nM and 25-400 nM for other caspases including caspase 1, 3, 8, 9, 10, and 12. Q-VD-OPh can inhibits HIV infection. Q-VD-OPh is able to cross the blood-brain barrier.
loading...
    loading...
Referencia número: HY-16521
No. CAS: 800408-39-3
Target:  

Caspase

Áreas de investigación:  

Inflammation/Immunology

VX-166, a pan caspase inhibitor, can be used for the research of Non- Alcoholic Fatty Liver Disease (NAFLD), nonalcoholic steatohepatitis (NASH), alcoholic steatohepatitis (ASH), and other diseases involving fibrosis, steatosis, or inflammation of the liver .
loading...
    loading...
Referencia número: HY-16658BG
No. CAS: 161401-82-7
Z-VAD-FMK is a pan-caspase inhibitor and also an ICE-like protease inhibitor, which inhibits apoptosis by preventing the processing of CPP32 to its active form. Z-VAD-FMK sensitivity varies primarily due to differential expression of receptor-interacting protein 1 (RIP1). Z-VAD-FMK limits the cryopreservation-induced apoptosis by reducing caspase-3 activity of in vitro produced bovine embryos. Z-VAD-FMK is immunosuppressive in vitro and inhibits T cell proliferation without blocking the processing of caspase-8 and caspase-3. Z-VAD-FMK leads to a decrease in intracellular glutathione (GSH) with a concomitant increase in reactive oxygen species (ROS) levels in activated T cells. Z-VAD-FMK is due to oxidative stress via the depletion of GSH. Z-VAD-FMK can be used for the study of acute pancreatitis .
loading...
    loading...
Referencia número: HY-117087
No. CAS: 1071544-43-8
Target:  

Phosphatase PANoptosis

Áreas de investigación:  

Cancer

K103 is an inhibitor discovered from the screen that is an analog of the serotonin antagonist benzazocine. K103 exhibited inhibition of SHIP homologues, labelling it a pan-SHIP1/2 inhibitor, but the molecule had no effect on another 5' inositol phosphatase, OCRL. In line with the "two PIPs hypothesis", the molecule exhibited significant anti-tumour effects against a variety of cell lines, particularly breast cancer cells. Additional studies with K103 revealed that inhibition of SHIP1/2 in multiple myeloma cells resulted in G2/M cell cycle arrest followed by extensive apoptosis via activation of the caspase cascade. K103 fits the commonly used small molecule agent property profile, but while this work was being conducted, it was discovered that K103 caused psychoactive effects in mice, which limited the utility of the molecule in vivo. Therefore, certain synthetic studies were conducted on this tryptamine to identify the features that needed to be present in the molecule to maintain pan-SHIP1/2 inhibition in order to design an inhibitor with favourable pharmacodynamic properties and an improved side effect profile.
loading...
    loading...
Referencia número: HY-P10243
No. CAS: 216008-80-9
Target:  

Caspase

Áreas de investigación:  

Neurological Disease

Ac-VAD-CMK is a pan inhibitor for caspase 1 .
loading...
    loading...